CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.
09 May 2025
09 May 2025
Total investments received (USD): 154.98M
Round value (USD): 120M
Company: CellCentric
Related deals
Vicebio was acquired by Sanofi for $1.6B
Secondary
14 July 2025
OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion
Secondary
14 July 2025
Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.
Investments
07 June 2025
Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain